Banco Bilbao Vizcaya Argentaria S.A. Boosts Stake in IDEXX Laboratories

The Spanish banking group increased its holdings in the veterinary diagnostics company by over 340% in the third quarter.

Mar. 17, 2026 at 7:35am

Banco Bilbao Vizcaya Argentaria S.A. (BBVA), a major Spanish banking group, significantly increased its stake in IDEXX Laboratories, Inc. (NASDAQ: IDXX) during the third quarter of 2026. According to a regulatory filing, BBVA's holdings in IDEXX Laboratories grew by 342.3%, with the bank now owning 14,140 shares of the veterinary diagnostics company's stock worth $9,011,000.

Why it matters

IDEXX Laboratories is a leading provider of diagnostic tools and services for the animal health industry. The substantial increase in BBVA's investment in the company suggests the Spanish bank sees strong growth potential in IDEXX's business, which could signal broader investor confidence in the veterinary diagnostics market.

The details

In its third-quarter filing with the Securities and Exchange Commission, BBVA disclosed that it had purchased an additional 10,943 shares of IDEXX Laboratories, bringing its total holdings to 14,140 shares. This represents a 342.3% increase in BBVA's position in the company compared to the prior quarter. IDEXX Laboratories is a global leader in providing diagnostic instruments, consumables, and software solutions to veterinary practices, livestock producers, and other customers in the animal health industry.

  • BBVA increased its IDEXX Laboratories holdings during the 3rd quarter of 2026.

The players

Banco Bilbao Vizcaya Argentaria S.A.

A major Spanish banking group that significantly increased its investment in IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.

A global provider of diagnostic tools and services for the animal health industry.

Got photos? Submit your photos here. ›

The takeaway

BBVA's substantial increase in its IDEXX Laboratories holdings suggests the Spanish bank sees strong growth potential in the veterinary diagnostics market, which could signal broader investor confidence in IDEXX's business and the animal health industry as a whole.